242 related articles for article (PubMed ID: 19932923)
1. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa.
Vivero-Escoto JL; Slowing II; Lin VS
Biomaterials; 2010 Feb; 31(6):1325-33. PubMed ID: 19932923
[TBL] [Abstract][Full Text] [Related]
2. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
Slowing I; Trewyn BG; Lin VS
J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins.
Slowing II; Trewyn BG; Lin VS
J Am Chem Soc; 2007 Jul; 129(28):8845-9. PubMed ID: 17589996
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
Zhao Y; Trewyn BG; Slowing II; Lin VS
J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
[TBL] [Abstract][Full Text] [Related]
5. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
6. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS
J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815
[TBL] [Abstract][Full Text] [Related]
7. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials.
Tao Z; Toms BB; Goodisman J; Asefa T
Chem Res Toxicol; 2009 Nov; 22(11):1869-80. PubMed ID: 19817448
[TBL] [Abstract][Full Text] [Related]
8. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent.
Radu DR; Lai CY; Jeftinija K; Rowe EW; Jeftinija S; Lin VS
J Am Chem Soc; 2004 Oct; 126(41):13216-7. PubMed ID: 15479063
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes.
Fisichella M; Dabboue H; Bhattacharyya S; Saboungi ML; Salvetat JP; Hevor T; Guerin M
Toxicol In Vitro; 2009 Jun; 23(4):697-703. PubMed ID: 19254755
[TBL] [Abstract][Full Text] [Related]
10. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles deliver DNA and chemicals into plants.
Torney F; Trewyn BG; Lin VS; Wang K
Nat Nanotechnol; 2007 May; 2(5):295-300. PubMed ID: 18654287
[TBL] [Abstract][Full Text] [Related]
12. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
13. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
14. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery.
Park IY; Kim IY; Yoo MK; Choi YJ; Cho MH; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):280-7. PubMed ID: 18490119
[TBL] [Abstract][Full Text] [Related]
15. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
16. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
Lin YS; Haynes CL
J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
[TBL] [Abstract][Full Text] [Related]
17. Luciferase and luciferin co-immobilized mesoporous silica nanoparticle materials for intracellular biocatalysis.
Sun X; Zhao Y; Lin VS; Slowing II; Trewyn BG
J Am Chem Soc; 2011 Nov; 133(46):18554-7. PubMed ID: 22007786
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems.
Trewyn BG; Giri S; Slowing II; Lin VS
Chem Commun (Camb); 2007 Aug; (31):3236-45. PubMed ID: 17668088
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L
J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
